Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Withdrawn × Prostatic Neoplasms × Clear all

Phase

Phase NA 59 Phase 2 54 Phase 1 16 Phase 3 14 Phase 1/2 9 Phase EARLY_PHASE1 7 Phase 4 1 Phase 2/3 1

Status

Completed 52 Unknown 14 Recruiting 12 Terminated 9 Active not recruiting 6 Suspended 2 Not yet recruiting 2 Withdrawn 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 9 Neoplasms 8 Polycystic Ovary Syndrome 7 Infertility 4 Pain, Postoperative 3 Liver Neoplasms 3 Urinary Bladder Neoplasms 2 Recurrence 2 Pulmonary Embolism 2 Neuroma, Acoustic 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma, Follicular 2 Lung Neoplasms 2 Leiomyoma 2 Inflammation 2 Head and Neck Neoplasms 2 Febrile Neutropenia 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Bites and Stings 2 Anovulation 2 Vomiting 1 Venous Thrombosis 1 Venous Thromboembolism 1 Unipolar Major Depression 1 Surgical Wound Infection 1 Stomatitis 1 Stomach Neoplasms 1 Sleep Initiation and Maintenance Disorders 1

Interventions

2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05568537 2025-01-03

Prostate MRI and Pylarify PSMA PET/CT

Corewell Health East

Phase 4 Withdrawn

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡